The analyst's Medical Devices sector report, “Renal Denervation Catheters Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Renal Denervation Catheters pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Renal denervation, also known as renal sympathetic denervation (RSD), is a minimally invasive, catheter-based endovascular procedure that utilizes radiofrequency energy or ultrasound energy to ablate nerves in the walls of the renal artery, causing a reduction in the nerve activity which ultimately reduces the blood pressure in patients with resistant hypertension.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Renal denervation, also known as renal sympathetic denervation (RSD), is a minimally invasive, catheter-based endovascular procedure that utilizes radiofrequency energy or ultrasound energy to ablate nerves in the walls of the renal artery, causing a reduction in the nerve activity which ultimately reduces the blood pressure in patients with resistant hypertension.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Renal Denervation Catheters under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Renal Denervation Catheters and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy
The report enables you to :
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Renal Denervation Catheters under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Table of Contents
1 Table of Contents
2 Introduction
3 Products under Development
4 Renal Denervation Catheters - Pipeline Products under Development by Companies
5 Renal Denervation Catheters Companies and Product Overview
7 Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Vascular Inc
- Ablative Solutions Inc
- Brattea
- CryoMedix, LLC.
- Handok-Kalos Medical
- Johns Hopkins University
- Kona Medical Inc
- Lepu Medical Technology (Beijing) Co Ltd
- Lifetech Scientific (Shenzhen) Co Ltd
- Mayo Clinic
- Medtronic Plc
- MicroPort Scientific Corp
- Northwind Medical Inc
- Rainmed Medical Ltd
- ReCor Medical Inc
- Renal Dynamics, LLC
- Renaly Ltd
- Shanghai AngioCare Medical Technology Co Ltd
- Shanghai Golden Leaf Medtech Co Ltd
- SoniVie Ltd.
- Sound Interventions, Inc.
- St. Jude Medical LLC
- Suzhou Xinmai Medical Equipment Co Ltd
- Symple Surgical Inc
- Tel Aviv University
- Terumo Interventional Systems
- University of Sydney
- Venus Medtech Hangzhou Inc
- Verve Medical, Inc.
